Cambridge Cancer Genomics Company

Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.
Technology: Biotechnology, Health Care, Health Diagnostics, Medical
Industry: AI in Pharma, Early Drug Development
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: M&A
Investors Number: 10
Total Funding: 8500000
Estimated Revenue: Less than $1M
Last Funding Date: 2018-12-31
Last Funding Type: Seed

Visit Website
Register and Claim Ownership